WHO ICTRP trial

A study of multiple different dosages of JNJ 39758979 and placebo in patients…

EUCTR2011-002849-36-LV · EU Clinical Trials Register · Not Recruiting

Key facts

Trial ID EUCTR2011-002849-36-LV
Public title A study of multiple different dosages of JNJ 39758979 and placebo in patients with active Rheumatoid Arthritis
Scientific title A Phase 2b Randomized, Double-blind, Multicenter, Placebo-controlled, Parallel-group, Dose Range Finding Study of JNJ-39758979 in Subjects with Active Rheumatoid Arthritis Despite Concomitant Methotrexate Therapy - not available
Primary sponsor Janssen-Cilag International NV
Registry EU Clinical Trials Register
Recruitment status Not Recruiting
Study type Interventional clinical trial of medicinal product
Countries United States;Ukraine;Russian Federation;Chile;Colombia;Czech Republic;Mexico;Argentina;Poland;Malaysia;Singapore;Romania;Latvia;Japan
Conditions Rheumatoid Arthritis MedDRA version: 14.0 Level: PT Classification code 10039073 Term: Rheumatoid arthritis System Organ Class: 10028395 - Musculoskeletal and connective tissue disorders ;Therapeutic area: Diseases [C] - Immune System…
Interventions Product Name: JNJ-39758979-AAC - enteric coated tablet - 10 mg Product Code: JNJ-39758979 Pharmaceutical Form: Gastro-resistant tablet INN or Proposed INN: Not assigned CAS Number: Not assigned Current Sponsor code: JNJ-39758979-AAC Other…
Registration date Nov 22, 2011
Target size 325
Secondary IDs 39758979ARA2001
Registry page clinicaltrialsregister.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations